Results 31 to 40 of about 599,782 (127)

CCR5 haplotypes influence HCV serostatus in Caucasian intravenous drug users. [PDF]

open access: yesPLoS ONE, 2013
Up to 90% HIV-1 positive intravenous drug users (IDUs) are co-infected with HCV. Although best recognized for its function as a major co-receptor for cell entry of HIV, CC chemokine receptor 5 (CCR5) has also been implicated in the pathogenesis of HCV ...
Kristi Huik   +16 more
doaj   +1 more source

Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status

open access: yesFrontiers in Immunology, 2023
BackgroundThe lower burden of COVID-19 in tropical settings may be due to preexisting cross-immunity, which might vary according to geographical locations and potential exposure to other pathogens. We sought to assess the overall prevalence of SARS-CoV-2
Abba Aissatou   +43 more
doaj   +1 more source

Reaching the unreached: Performance of an enhanced peer outreach approach to identify new HIV cases among female sex workers and men who have sex with men in HIV programs in West and Central Africa.

open access: yesPLoS ONE, 2019
Finding new HIV-positive cases remains a priority to achieve the UNAIDS goals. An enhanced peer outreach approach (EPOA) was implemented to expand the delivery of HIV services to female sex workers (FSWs) and men who have sex with men (MSM) in three ...
Tiffany A Lillie   +10 more
doaj   +1 more source

HIV seropositivity in high risk individuals and in pulmonary tuberculosis [PDF]

open access: yes, 2017
Background: The association between tuberculosis and HIV has been well known. South Asia especially India is witnessing largest number of new AIDS cases and the epidemic is well established. TB shortens the life expectancy of HIV positive people. Keeping
Gupta, Abhishek   +4 more
core   +1 more source

Seroprevalence of Human Herpesvirus-8 in HIV-1 Infected and Uninfected Individuals in Cameroon

open access: yesViruses, 2013
We evaluated the prevalence of HHV-8 antibodies in 516 plasma samples collected from HIV positive and negative patients from blood banks and urban areas of Cameroon.
Owen Wood   +5 more
doaj   +1 more source

Anti-HIV seropositivity among different group of patients; an observation from a secondary medical center in an endemic area of HIV infection [PDF]

open access: yesJournal of Preventive Epidemiology, 2019
Human immunodeficiency virus (HIV) infection is an important medical problem worldwide. Since there is still no curative treatment, the good management for the HIV infected patient is necessary.
Pathum Sookaromdee, Viroj Wiwanitkit
doaj  

Association of Patients’ Geographic Origins with Viral Hepatitis Co-infection Patterns, Spain

open access: yesEmerging Infectious Diseases, 2011
To determine if hepatitis C virus seropositivity and active hepatitis B virus infection in HIV-positive patients vary with patients’ geographic origins, we studied co-infections in HIV-seropositive adults.
Santiago Pérez Cachafeiro   +10 more
doaj   +1 more source

“An Extra Variable to Consider”—Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials

open access: yes, 2022
Our study explores the understanding of vaccine-induced seropositivity (VISP) and its potential impact on US adolescents' and caregivers' willingness to participate in adolescent HIV vaccine clinical trials. Findings from in-depth interviews suggest that
Perry, Brian   +15 more
core   +1 more source

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui   +10 more
wiley   +1 more source

Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration

open access: yesArthritis &Rheumatology, EarlyView.
Objective To develop, externally validate, and simplify a machine learning model to predict remission between 6 and 24 months in patients with rheumatoid arthritis (RA) initiating tumor necrosis factor inhibitors, JAK inhibitors, interleukin‐6 inhibitors, abatacept, or rituximab using data from 11 international registries in the JAK‐pot collaboration ...
Zubeyir Salis   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy